Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 17 Neoplasms 9 Polycystic Ovary Syndrome 7 Multiple Myeloma 4 Vomiting 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Nausea 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Gain 1

Interventions

Metformin 5 Educational Status 3 Tirzepatide 2 Surveys and Questionnaires 2 Standard of Care 2 Specimen Handling 2 Pioglitazone 2 Nutrition Assessment 2 Methods 2 Interviews as Topic 2 Glucose Tolerance Test 2 Exercise 2 tocilizumab 1 sofosbuvir-velpatasvir drug combination 1 saxagliptin 1 pembrolizumab 1 otelixizumab 1 nabiximols 1 esmolol 1 dapagliflozin 1 Verapamil 1 Urine Specimen Collection 1 Testosterone 1 Tablets 1 Secretin 1 Second Harmonic Generation Microscopy 1 Risk Assessment 1 Preventive Health Services 1 Practice Guidelines as Topic 1 Phlebotomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04233034 2024-11-27

CLVer

Jaeb Center for Health Research

Phase 3 Completed

113 enrolled 42 charts

Other hematologic neoplasm

Diabetes Mellitus, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡